SCHEMBL19684344

SCHEMBL19684344

NC(=O)C1(c2cc(Cl)nc(N3CCOCC3)n2)CC1

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ HTT P42858 3/20 0.47
▸ KDM4E B2RXH2 2/20 0.47
▸ CYP1A2 P05177 1/20 0.45
▸ CYP2D6 P10635 1/20 0.45
▸ MAPT P10636 1/20 0.45
▸ POLB P06746 2/20 0.42
▸ LMNA P02545 1/20 0.42
▸ HSD17B10 Q99714 1/20 0.42
▸ GPR55 Q9Y2T6 1/20 0.42
▸ KMT2A Q03164 5/20 0.39
▸ SMN1; SMN2 Q16637 2/20 0.39
▸ TSHR P16473 1/20 0.39
▸ PIK3CA P42336 5/20 0.39
▸ MTOR P42345 1/20 0.39
▸ PIK3CG P48736 1/20 0.39
▸ MEN1 O00255 3/20 0.38
▸ PIK3R1 P27986 2/20 0.38
▸ RAF1 P04049 1/20 0.38
▸ BRAF P15056 1/20 0.38
▸ MAPK1 P28482 2/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17859909 0.88 CYP1A2 (0.43) HTTKDM4ECYP1A2CYP2D6MAPT
SCHEMBL19678674 0.87 CYP1A2 (0.42) HTTKDM4ECYP1A2CYP2D6MAPT
SCHEMBL17859914 0.86 ALDH1A1 (0.45) HTTKDM4ECYP1A2CYP2D6MAPT
SCHEMBL17859827 0.81 POLB (0.43) KDM4ECYP1A2POLBLMNAHSD17B10
SCHEMBL19678675 0.80 PIK3CA (0.38) HTTKDM4ECYP1A2CYP2D6MAPT
SCHEMBL17859834 0.80 MAPT (0.47) HTTKDM4ECYP1A2CYP2D6MAPT
SCHEMBL17859916 0.79 RAF1 (0.37) KDM4ECYP1A2CYP2D6MAPTKMT2A
SCHEMBL17859809 0.77 PIK3CA (0.57) PIK3CAMTORPIK3CGPIK3R1
SCHEMBL17859846 0.77 ALDH1A1 (0.45) HTTKDM4EMAPTHSD17B10KMT2A
SCHEMBL17859925 0.76 RAF1 (0.47) HTTKDM4ECYP1A2CYP2D6MAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20170349568-A1 2-MORPHOLIN-4,6-DISUBSTITUTED PYRIMIDINE DERIVATIVE, AND PREPARATION METHOD AND PHARMACEUTICAL USE THEREOF YANGTZE RIVER PHARMACEUTICAL GROUP CO., LTD. (CN) 2017-12-07 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20170349568-A1 2-MORPHOLIN-4,6-DISUBSTITUTED PYRIMIDINE DERIVATIVE, AND PREPARATION METHOD AND PHARMACEUTICAL USE THEREOF PIK3CA, PIK3CD, PIK3CG HTT 4041/4885KDM4E 1738/4885CYP1A2 1011/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback